2019 Novel Coronavirus (COVID-19) With Respiratory Syncytial Virus, NAA
Also known as: 2019 Novel Coronavirus, COVID-19, Respiratory Viral panel, SARS-CoV-2
Use
Results are for the identification and differentiation of RNA from SARS-CoV-2 and RSV.
Special Instructions
Not provided.
Limitations
The assay is authorized under the FDA's Emergency Use Authorization for the detection of SARS-CoV-2 and RSV. It is not FDA cleared or approved but is permitted for use due to the ongoing public health emergency. Negative results do not rule out the possibility of infection, especially if exposure to the virus has occurred recently or if symptoms are present. Analytical sensitivity may be affected by variations in viral mutations, although no impact has been observed to date.
Methodology
PCR-based (RT-PCR)
Biomarkers
RSV
MicroorganismSARS-CoV-2
Microorganism
LOINC Codes
- 78922-2 - Resp path DNA+RNA Pnl Nph NAA+probe
- 94759-8 - SARS-CoV-2 RNA Nph Ql NAA+probe
- 76089-2 - RSV RNA Nph Ql NAA+probe
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Nasal Swab
Volume
1 - 3 mL
Minimum Volume
1 mL
Container
Anterior nasal swab, nasopharyngeal (NP) swab or mid-turbinate swab in viral/universal transport medium (VTM/UTM) or 0.9% saline
Collection Instructions
Insert the tip of the swab into one nostril until it is no longer visible. Rotate three times. Repeat in the other nostril. Insert swab into saline/UTM/VTM and cap tightly.
Storage Instructions
Frozen at -20° C (preferred); acceptable if refrigerated or at room temp within 72 hours.
Causes for Rejection
Specimens beyond stability limits, improperly labeled, contaminated, broken, leaking, or with inhibitory substances like heparin, hemoglobin, ethanol, or >0.01M EDTA. Must be submitted with a swab.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 72 hours |
| Frozen | > 72 hours |
Other tests from different labs that may be relevant